Iovance Biotherapeutics
IOVA
IOVA
257 hedge funds and large institutions have $3.88B invested in Iovance Biotherapeutics in 2020 Q2 according to their latest regulatory filings, with 74 funds opening new positions, 92 increasing their positions, 66 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $3.73B → $3.88B (+$148M)
2.21% less ownership
Funds ownership: 98.46% → 96.25% (-2.2%)
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
Holders
257
Holding in Top 10
9
Calls
$69.1M
Puts
$23.7M
Top Buyers
| 1 | +$91.9M | |
| 2 | +$50.4M | |
| 3 | +$45M | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
+$44.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$39.3M |
Top Sellers
| 1 | -$47.6M | |
| 2 | -$45.1M | |
| 3 | -$30.9M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$27.3M |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$21.9M |